Cargando…

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

Glioblastoma (GBM) is the most common primary brain tumor in adults and has a dismal prognosis despite multimodality treatment. Given the resistance of glioma stem cells (GSC) to chemotherapy and radiation therapy, their eradication could prevent tumor recurrence. We sought to evaluate the antitumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allen, Cory, Opyrchal, Mateusz, Aderca, Ileana, Schroeder, Mark A., Sarkaria, Jann N., Domingo, Evidio, Federspiel, Mark J., Galanis, Evanthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509233/ https://www.ncbi.nlm.nih.gov/pubmed/22914495 http://dx.doi.org/10.1038/gt.2012.62

Ejemplares similares

Measles Edmonston Vaccine Strain Derivatives have Potent Oncolytic Activity against Osteosarcoma
por: Musibay, Evidio Domingo, et al.
Publicado: (2014)

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy
por: Iankov, Ianko D., et al.
Publicado: (2015)

Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion
por: Huveldt, Deborah, et al.
Publicado: (2013)

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H.pylori immunostimulatory bacterial transgene
por: Viker, Kimberly B., et al.
Publicado: (2022)

Live Attenuated Measles Virus Vaccine Expressing Helicobacterpylori Heat Shock Protein A
por: Iankov, Ianko D., et al.
Publicado: (2020)

Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
por: Hutzen, Brian, et al.
Publicado: (2012)

Interferon signaling predicts response to oncolytic virotherapy
por: Kurokawa, Cheyne, et al.
Publicado: (2019)

Measles to the Rescue: A Review of Oncolytic Measles Virus
por: Aref, Sarah, et al.
Publicado: (2016)

Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)

Measles virus: Background and oncolytic virotherapy
por: Bhattacharjee, Sankhajit, et al.
Publicado: (2018)

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
por: Baldo, Aline, et al.
Publicado: (2015)

In Vivo Safety, Biodistribution and Antitumor Effects of uPAR Retargeted Oncolytic Measles Virus in Syngeneic Cancer Models
por: Jing, Yuqi, et al.
Publicado: (2014)

A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity
por: Nosaki, Kaname, et al.
Publicado: (2016)

Advances in the design and development of oncolytic measles viruses
por: Hutzen, Brian, et al.
Publicado: (2015)

Engineering and combining oncolytic measles virus for cancer therapy
por: Leber, Mathias F., et al.
Publicado: (2020)

Endogenous Heat‐Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma
por: Domingo‐Musibay, Evidio, et al.
Publicado: (2017)

Oncolytic adenoviruses: A thorny path to glioma cure
por: Ulasov, I.V., et al.
Publicado: (2014)

Updates to the antitumor mechanism of oncolytic virus
por: Bai, Yang, et al.
Publicado: (2019)

PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities
por: Sim, Hao-Wen, et al.
Publicado: (2022)

The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
por: Martínez-Vélez, Naiara, et al.
Publicado: (2019)

Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020)

Attenuated measles vaccine strain have potent oncolytic activity against Iraqi patient derived breast cancer cell line
por: Abdullah, Sulaiman A., et al.
Publicado: (2020)

In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution
por: Kemler, Iris, et al.
Publicado: (2018)

Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus
por: Scheubeck, Gabriel, et al.
Publicado: (2019)

A Combined Ultrafiltration/Diafiltration Process for the Purification of Oncolytic Measles Virus
por: Loewe, Daniel, et al.
Publicado: (2022)

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer
por: Singh, Hans Martin, et al.
Publicado: (2021)

Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine
por: Engeland, Christine E.
Publicado: (2022)

Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference †
por: Anker, Sophie C., et al.
Publicado: (2023)

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022)

Antitumor Virotherapy by Attenuated Measles Virus (MV)
por: Guillerme, Jean-Baptiste, et al.
Publicado: (2013)

Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues
por: Zhou, Dan, et al.
Publicado: (2018)

Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs
por: Zhang, Liang, et al.
Publicado: (2015)

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014)

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites
por: Leber, Mathias Felix, et al.
Publicado: (2018)

Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma
por: Jacobson, Blake A., et al.
Publicado: (2017)

Aeration and Shear Stress Are Critical Process Parameters for the Production of Oncolytic Measles Virus
por: Grein, Tanja A., et al.
Publicado: (2019)

Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy
por: Xia, Mao, et al.
Publicado: (2019)

Current strategies in engaging oncolytic viruses with antitumor immunity
por: Boagni, Drew Ashton, et al.
Publicado: (2021)

MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum
por: Muñoz-Alía, Miguel Ángel, et al.
Publicado: (2021)

Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas
por: Higgins, Dominique M. O., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6aoe73m93vsrbfjnd05alvq12r